MAJOR BLEEDING IN PATIENTS WITH PERIPHERAL ARTERY DISEASE: INSIGHTS FROM THE EUCLID TRIAL

Rates and predictors of major bleeding events in patients with peripheral artery disease (PAD) treated with antiplatelet medications are not known. This post-hoc analysis of EUCLID aimed to (1) determine the incidence of minor/major bleeding; (2) determine the predictors of major bleeding; and (3)